Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020

Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1.1 Research Methodology Steps
2.1.2 Secondary and Primary Research Methodology
2.1.2.1 Secondary Research
2.1.2.2 Key Data From Secondary Sources
2.1.2.3 Primary Research
2.1.2.4 Key Industry Insights
2.1.5 Key Data From Primary Sources
2.1.6 Key Insights From Primary Sources
2.1.7 Market Size Estimation Methodology
2.1.8 Market Forecast Methodology
2.1.9 Market Data Validation and Triangulation
2.1.10 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights
4.1 Global Cancer Diagnostics Market
4.2 Regional Snapshot of the Cancer Diagnostics Market
4.3 Cancer Diagnostics Market, By Technology (2015 vs. 2020)

5 Market Overview
5.1 Key Findings
5.2 Introduction
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising Prevalence of Cancer
5.3.1.2 Technological Advancements
5.3.1.3 Initiatives Undertaken By Governments and Global Health Organizations to Spread Awareness About Cancer
5.3.1.4 Growth in the Number of Private Diagnostic Centers
5.3.1.5 Public-Private Partnerships to Enhance the Infrastructure of Diagnostic Imaging Centers
5.3.1.6 Fda Support for Biomarker Development
5.3.1.7 Launch of New Flow Cytometry Reagents for Diagnostics and Drug Discovery
5.3.2 Restraints
5.3.2.1 High Capital Investments & Low Benefit-Cost Ratio for Biomarkers
5.3.2.2 Shortage of Helium
5.3.2.3 High Cost of Diagnostic Imaging Systems Affecting Their Rate of Adoption in Emerging Markets
5.3.2.4 Risk of High Radiation Exposure Likely to Limit the Usage of CT Scanners
5.3.2.5 Dearth of Skilled and Experienced Personnel
5.3.3 Opportunities
5.3.3.1 Personalized Medicine
5.3.3.2 Development of Mass Cytometry and the Combination of Cell-And Bead-Based Flow Cytometry Technologies
5.3.3.3 Companion Diagnostics
5.3.3.4 Improving Healthcare Infrastructure in Emerging Markets
5.3.3.5 Miniaturized and Technologically Advanced Devices
5.3.4 Challenges
5.3.4.1 Stringent Regulatory Guidelines
5.3.4.2 Hospital Budget Cuts A Key Challenge to Market Players
5.3.4.3 Increasing Adoption of Refurbished Diagnostic Imaging Systems

6 Global Cancer Diagnostics Market, By Technology
6.1 Introduction
6.2 Platform-Based Diagnostics
6.2.1 Polymerase Chain Reaction (PCR)
6.2.2 in Situ Hybridization (ISH)
6.2.3 Immunohistochemistry (IHC)
6.2.4 Next-Generation Sequencing (NGS)
6.2.5 Microarrays
6.2.6 Flow Cytometry
6.2.7 Other Technologies
6.3 Instrument-Based
6.3.1 Diagnostic Imaging
6.3.1.1 Magnetic Resonance Imaging (MRI)
6.3.1.2 Computed Tomography (Ct)
6.3.1.3 Positron Emission Tomography (PET)
6.3.1.3.1 Standalone Positron Emission Tomography
6.3.1.3.2 Hybrid Positron Emission Tomography
6.3.1.4 Mammography
6.3.1.5 Ultrasound
6.3.2 Biopsies

7 Global Cancer Diagnostics Market, By Application
7.1 Introduction
7.1.1 Breast Cancer
7.1.2 Lung Cancer
7.1.3 Colorectal Cancer
7.1.4 Melanoma
7.1.5 Other Cancers

8 Market, By End User

9 Cancer Diagnostics Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.1.1 Government Initiatives
9.2.1.2 Increase in Cancer Incidence
9.2.2 Canada
9.2.2.1 High Incidence of Cancer
9.2.2.2 Government Funding
9.3 Europe
9.3.1 Funding for Cancer Diagnostics Research
9.3.2 Eu-5 (U.K., Germany, France, Italy, Spain)
9.3.2.1 Strong Government Support
9.3.2.2 Research Collaborations
9.3.2.3 Increase in Diagnostic Imaging Centers
9.3.2.4 Rising Public and Private Investments
9.3.3 Rest of Europe (RoE)
9.3.3.1 Aging Population
9.3.3.2 Conferences Boosting Awareness
9.3.3.3 Government Investments in Russia
9.4 Asia
9.4.1.1 China
9.4.1.1.1 Expansion of International Players
9.4.1.1.2 Aging Population and Increasing Cancer Incidence
9.4.1.2 Japan
9.4.1.2.1 Aging Population and High Healthcare Expenditure in Japan
9.4.1.3 India
9.4.1.3.1 Increasing Focus of International Players on India
9.4.1.4 Rest of Asia
9.4.1.4.1 Presence of International Players Boosting Market Growth
9.5 Rest of the World (RoW)
9.5.1.1 Government Initiatives Boosting Demand for Cancer Diagnostics
9.5.1.2 Aging Population, Presence of International Players
9.5.1.3 Increase in Cancer Incidences and Rising Government Expenditure
9.5.1.4 Government Initiatives to Improve Healthcare Infrastructure

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
10.3.1 Collaborations/Agreements/Partnerships/Alliances
10.3.2 New Product Launches
10.3.3 Acquisitions
10.3.4 Expansion
10.3.5 Others

11 Company Profiles
11.1 Introduction
11.3 Becton, Dickinson and Company
11.3.1 Business Overview
11.3.2 Product Portfolio
11.3.3 Key Strategy
11.3.4 Recent Developments
11.4 GE Healthcare (A Subsidiary of General Electric Company)
11.4.1 Business Overview
11.4.2 Product Portfolio
11.4.3 Key Strategy
11.4.4 Recent Developments
11.5 Abbott
11.5.1 Business Overview
11.5.2 Product Portfolio
11.5.3 Key Strategy
11.5.4 Recent Developments
11.6 Roche
11.6.1 Business Overview
11.6.2 Product Portfolio
11.6.3 Key Strategy
11.6.4 Recent Developments
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Business Overview
11.7.2 Thermo Fisher Scientific, Inc.: Company Snapshot
11.7.3 Product Portfolio
11.7.4 Key Strategy
11.7.5 Recent Developments
11.8 Agilent Technologies, Inc.
11.8.1 Business Overview
11.8.2 Agilent Technologies, Inc.: Company Snapshot
11.8.3 Product Portfolio
11.8.4 Key Strategy
11.8.5 Recent Developments
11.9 Illumina, Inc.
11.9.1 Business Overview
11.9.2 Product Portfolio
11.9.3 Key Strategy
11.9.4 Recent Developments
11.10 Siemens Healthcare
11.10.1 Business Overview
11.10.2 Product Portfolio
11.10.3 Key Strategy
11.10.4 Recent Developments
11.11 C.R. Bard, Inc.
11.11.1 Business Overview
11.11.2 Product Portfolio
11.11.3 Key Strategy
11.11.4 Recent Developments

12 Appendix
12.1 Discussion Guide
12.2 Available Customizations
12.3 Related Reports
12.4 Introducing RT: Real-Time Market Intelligence

List of Tables (89 Tables)

Table 1 Rising Prevalence of Cancer is Driving the Growth of the Cancer Diagnostics Market
Table 2 High Capital Investment Restraining the Growth of this Market
Table 3 Emerging Markets Present an Array of Opportunities for the Growth of this Market
Table 4 Stringent Regulatory Guidelines are A Major Challenge in the Cancer Diagnostics Market
Table 5 Global Cancer Diagnostics Market Size, By Technology, 2013–2020 ($Million)
Table 6 Global Market Size, By Technology, 2013–2020 ($Million)
Table 7 Market Size for Platform-Based Diagnostics, By Region, 2013–2020 ($Million)
Table 8 Global Market Size for PCR, By Region, 2013–2020 ($Million)
Table 9 Global Market Size for PCR, By Application, 2013–2020 ($Million)
Table 10 Cancer Diagnostics Market Size for in Situ Hybridization, By Region, 2013-2020 ($Million)
Table 11 Global Market Size for in Situ Hybridization, By Application, 2013–2020 ($Million)
Table 12 Market Size for Immunohistochemistry, By Region, 2013–2020 ($Million)
Table 13 Global Market Size for Immunohistochemistry, By Application, 2013–2020 ($Million)
Table 14 Market Size for NGS, By Region, 2013–2020 ($Million)
Table 15 Global Market Size for NGS, By Application, 2013–2020 ($Million)
Table 16 Market Size for Microarrays, By Region, 2013–2020 ($Million)
Table 17 Global Market Size for Microarrays, By Application, 2013–2020 ($Million)
Table 18 Market Size for Flow Cytometry, By Region, 2013–2020 ($Million)
Table 19 Global Market Size for Flow Cytometry, By Application,  2013–2020 ($Million)
Table 20 Market Size for Other Technologies, By Region, 2013–2020 ($Million)
Table 21 Global Market Size for Other Technologies, By Application, 2013–2020 ($Million)
Table 22 Global Market Size, By Technology, 2013–2020 ($Million)
Table 23 Cancer Diagnostics Market Size for Diagnostic Imaging, By Product, 2013–2020 ($Million)
Table 24 Market Size for Diagnostic Imaging, By Region, 2013–2020 ($Million)
Table 25 Global Market Size for Imaging, By Application, 2013–2020 ($Million)
Table 26 Cancer Diagnostics Market Size for MRI, By Region, 2013–2020 ($Million)
Table 27 Market Size for CT, By Region, 2013–2020 ($Million)
Table 28 Market Size for PET, By Product, 2013–2020 ($Million)
Table 29 Market Size for PET, By Region, 2013–2020 ($Million)
Table 30 Market Size for Standalone PET, By Region, 2013–2020 ($Million)
Table 31 Market Size for Hybrid PET, By Region, 2013–2020 ($Million)
Table 32 Market Size for Mammography, By Region, 2013–2020 ($Million)
Table 33 Market Size for Ultrasound, By Region, 2013–2020 ($Million)
Table 34 Cancer Diagnostics Market Size for Biopsy, By Region, 2013–2020 ($Million)
Table 35 Global Market Size for Biopsy, By Application, 2013–2020 ($Million)
Table 36 Global Market Size, By Application, 2013–2020 ($Million)
Table 37 Market Size for Breast Cancer, By Region, 2013–2020 ($Million)
Table 38 Market Size for Lung Cancer, By Region, 2013–2020 ($Million)
Table 39 Market Size for Colorectal Cancer, By Region, 2013–2020 ($Million)
Table 40 Market Size for Melanoma, By Region, 2013–2020 ($Million)
Table 41 Cancer Diagnostics Market Size for Other Cancers, By Region, 2013–2020 ($Million)
Table 42 North America Market, By Country, 2013–2020 ($Million)
Table 43 North America: Market, By Technology, 2013–2020 ($Million)
Table 44 North America: Cancer Diagnostics Platform-Based Market, By Technology, 2013–2020 ($Million)
Table 45 North America: Cancer Diagnostics Instrument-Based Market, By Technology, 2013–2020 ($Million)
Table 46 North America: Market, By Application, 2013–2020 ($Million)
Table 47 U.S.: Market, By Technology, 2013–2020 ($Million)
Table 48 U.S.: Cancer Diagnostics Platform-Based Market, By Technology, 2013–2020 ($Million)
Table 49 U.S.: Cancer Diagnostics Instrument-Based Market, By Technology, 2013–2020 ($Million)
Table 50 Canada: Market, By Technology, 2013–2020 ($Million)
Table 51 Canada: Cancer Diagnostics Platform-Based Market, By Technology, 2013–2020 ($Million)
Table 52 Canada: Cancer Diagnostics Instrument-Based Market, By Technology, 2013–2020 ($Million)
Table 53 Europe: Market, By Region, 2013–2020 ($Million)
Table 54 Europe: Market, By Technology, 2013–2020 ($Million)
Table 55 Europe: Cancer Diagnostics Platform-Based Market, By Technology, 2013–2020 ($Million)
Table 56 Europe: Cancer Diagnostics Instrument Market, By Technology, 2013–2020 ($Million)
Table 57 Europe: Market, By Application, 2013–2020 ($Million)
Table 58 EU-5: Market, By Technology, 2013–2020 ($Million)
Table 59 EU-5: Cancer Diagnostics Platform-Based Market, By Technology, 2013–2020 ($Million)
Table 60 EU-5: Cancer Diagnostics Instrument-Based Market, By Technology, 2013–2020 ($Million)
Table 61 RoE: Market, By Technology, 2013–2020 ($Million)
Table 62 RoE: Cancer Diagnostics Platform-Based Market, By Technology, 2013–2020 ($Million)
Table 63 RoE: Cancer Diagnostics Instrument-Based Market, By Technology, 2013–2020 ($Million)
Table 64 Asia: Market, By Country, 2013–2020 ($Million)
Table 65 Asia: Market, By Technology, 2013–2020 ($Million)
Table 66 Asia: Cancer Diagnostics Platform-Based Market, By Technology, 2013–2020 ($Million)
Table 67 Asia: Cancer Diagnostics Instrument-Based Market, By Technology, 2013–2020 ($Million)
Table 68 Asia: Market, By Application, 2013–2020 ($Million)
Table 69 China: Market, By Technology, 2013–2020 ($Million)
Table 70 China: Cancer Diagnostics Platform-Based Market, By Technology, 2013–2020 ($Million)
Table 71 China: Cancer Diagnostics Instrument-Based Market, By Technology, 2013–2020 ($Million)
Table 72 Japan: Market, By Technology, 2013–2020 ($Million)
Table 73 Japan: Cancer Diagnostics Platform-Based Market, By Technology, 2013–2020 ($Million)
Table 74 Japan: Cancer Diagnostics Instrument-Based Market, By Technology, 2013–2020 ($Million)
Table 75 India: Market, By Technology, 2013–2020 ($Million)
Table 76 India: Cancer Diagnostics Platform-Based Market, By Technology, 2013–2020 ($Million)
Table 77 India: Cancer Diagnostics Instrument-Based Market, By Technology, 2013–2020 ($Million)
Table 78 RoA: Market, By Technology, 2013–2020 ($Million)
Table 79 RoA: Cancer Diagnostics Platform-Based Market, By Technology, 2013–2020 ($Million)
Table 80 RoA: Cancer Diagnostics Instrument-Based Market, By Technology, 2013–2020 ($Million)
Table 81 RoW: Market, By Technology, 2013–2020 ($Million)
Table 82 RoW: Cancer Diagnostics Platform-Based Market, By Technology, 2013–2020 ($Million)
Table 83 RoW: Cancer Diagnostics Instrument-Based Market, By Technology, 2013–2020 ($Million)
Table 84 RoW: Market, By Application, 2013–2020 ($Million)
Table 85 Collaborations/Agreements/Partnerships/Alliances, 2012-2015
Table 86 New Product Launches, 2012–2015
Table 87 Acquisitions, 2012–2015
Table 88 Expansions, 2012–2015
Table 89 Other Strategies, 2012–2015

List of Figures

Figure 1 Cancer Diagnostics Market Segmentation
Figure 2 Global Cancer Diagnostics Market : Research Methodology Steps
Figure 3 Sampling Frame: Primary Research
Figure 4 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Market Forecast Methodology
Figure 8 Data Triangulation Methodology
Figure 9 Platform-Based Diagnostics to Witness Highest CAGR of 25.3% From 2015 to 2020
Figure 10 Global Platform-Based Cancer Diagnostics Market Share, By Technology, 2015–2020
Figure 11 Global Cancer Diagnostics Market, By Geography
Figure 12 Largest and Fastest-Growing Cancer Diagnostic Applications, 2015-2020
Figure 13 Cancer Diagnostics Market Likely to Grow at A CAGR of 12.9% in the Forecast Period
Figure 14 Market, By Region and Application: North America Will Dominate the Cancer Diagnostics Market in 2015
Figure 15 Asia to Witness the Highest Growth Rate During the Forecast Period
Figure 16 Instrument-Based Technology Will Command Largest Market Share
Figure 17 Market: Drivers, Restraints, Opportunities, & Challenges
Figure 18 NGS, A Ground-Breaking Technology in Cancer Diagnosis
Figure 19 Ultrasound Accounted for the Largest Share of the Cancer Diagnostics Market for Imaging
Figure 20 Market Growth Will Be Driven By Rising Incidence & Prevalence of Breast and Lung Cancers
Figure 21 Lung Cancer Application is Expected to Grow at the Highest CAGR in the Forecast Period
Figure 22 New Product Launches Was the Key Growth Strategy for Market Players
Figure 23 Global NGS Market (For Cancer Diagnostics) Share Analysis, By Key Player, 2014
Figure 24 Global Microarrays Market (For Cancer Diagnostics) Share Analysis, By Key Player, 2014
Figure 25 Global Flow Cytometry (For Cancer Diagnostics) Market Share Analysis, By Key Player, 2014
Figure 26 Global MRI Imaging Market Share Analysis, By Key Player, 2014
Figure 27 Global CT Imaging Market Share Analysis, By Key Player, 2014
Figure 28 Global PET Imaging Market Share Analysis, By Key Player, 2014
Figure 29 Global Ultrasound Imaging Market Share Analysis, By Key Player, 2014
Figure 30 Battle for Market Share: Collaborations/Agreements/Partnerships/ Alliances Were Key Strategies
Figure 31 Becton, Dickinson and Company: Company Snapshot
Figure 32 GE Healthcare: Company Snapshot
Figure 33 Abbott: Company Snapshot
Figure 34 Roche Diagnostics: Company Snapshot
Figure 35 Illumina, Inc.: Company Snapshot
Figure 36 Siemens: Company Snapshot
Figure 37 C.R. Bard, Inc.: Company Snapshot

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Prostate Cancer Diagnostics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Prostate Cancer Diagnostics market size was valued at US$ 13140 million in 2023. With growing demand in downstream market, the Prostate Cancer Diagnostics is forecast to a readjusted size of US$ 22650 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global Prostate Cancer Diagnostics market. Prostate Cancer Diagnostics are expected to show stable growth in th......

Global Checkpoint Inhibitors for Treating Cancer Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 83

According to our LPI (LP Information) latest study, the global Checkpoint Inhibitors for Treating Cancer market size was valued at US$ 12220 million in 2023. With growing demand in downstream market, the Checkpoint Inhibitors for Treating Cancer is forecast to a readjusted size of US$ 63530 million by 2030 with a CAGR of 26.6% during review period. The research report highlights the growth potential of the global Checkpoint Inhibitors for Treating Cancer market. Checkpoint Inhibitors for......

Global PSA Test Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111

According to our LPI (LP Information) latest study, the global PSA Test market size was valued at US$ 499.9 million in 2023. With growing demand in downstream market, the PSA Test is forecast to a readjusted size of US$ 861.8 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global PSA Test market. PSA Test are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global HPV Testing Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87

According to our LPI (LP Information) latest study, the global HPV Testing market size was valued at US$ 784.6 million in 2023. With growing demand in downstream market, the HPV Testing is forecast to a readjusted size of US$ 1398.7 million by 2030 with a CAGR of 8.6% during review period. The research report highlights the growth potential of the global HPV Testing market. HPV Testing are expected to show stable growth in the future market. However, product differentiation, reducing cos......

Global Prostate Cancer Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 102

According to our (Global Info Research) latest study, the global Prostate Cancer Diagnostics market size was valued at USD 13820 million in 2023 and is forecast to a readjusted size of USD 22870 million by 2030 with a CAGR of 7.5% during review period. The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be ......

Global Pap Tests and HPV Tests Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 130

The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......

Global Pap Tests and HPV Tests Professional Survey Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 3280 Onwards        Pages: 106

The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......

Global Checkpoint Inhibitors For Treating Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Checkpoint Inhibitors For Treating Cancer market: According to our latest research, the global Checkpoint Inhibitors For Treating Cancer market looks promising in the next 5 years. As of 2022, the global Checkpoint Inhibitors For Treating Cancer market was estimated at USD 18595.4 million, and it's anticipated to reach USD 42557.61 million in 2028, with a CAGR of 14.8% during the forecast years. Checkpoint inhibitor is a type of drug used in immunoth......

Global Solid Tumor Testing Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 100

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs